Participation and Input

Federal Participation and Input

The National Vaccine Program in the Office of Infectious Disease and HIV/AIDS Policy (OIDP) leads and coordinates the development of Vaccines National Strategic Plan 2021-2025 (Vaccine Plan) and Vaccines Federal Implementation Plan. It does this in collaboration with the federal Interagency Vaccine Working Group, which was organized to set the vision, goals, objectives, and strategies for the National Vaccine Plan.

The agencies represented in this working group are:

• Agency for Healthcare Research and Quality
• Assistant Secretary for Preparedness and Response
• Biomedical Advanced Research and Development Authority, ASPR
• Centers for Disease Control and Prevention
• Centers for Medicare & Medicaid Services
• Food and Drug Administration
• Health Resources and Services Administration
• Indian Health Service
• National Institutes of Health
• Office of Global Affairs
• Office of Infectious Disease and HIV/AIDS Policy, National Vaccine Program
• Office of the National Coordinator for Health Information Technology

On an ongoing basis, the National Vaccine Program engages a wide range of federal leadership, experts, and non-federal partners to identify topics and develop recommendations to enhance all aspects of vaccines and vaccination, including research and development, safety, vaccine knowledge and confidence, increased access and use of routinely recommended vaccines, and global cooperation.

Public Participation and Input

The Vaccine Plan was informed by telephone interviews with 65 leading experts in vaccine science, program management, policy, and advocacy. It was also informed by public input collected through announcements in the Federal Register. Details on how the plan was developed can be found in Appendix A of the Vaccine Plan.

The Vaccines Federal Implementation Plan was informed by input from federal agencies about the actions they are taking to advance the goals of the Vaccine Plan. It was also informed by written public comment submitted in response to  two separate announcements in the Federal Register.

OIDP also released national strategic plans for viral hepatitis, sexually transmitted infections, and HIV between December 2020 and January 2021. Learn more about the Vaccine Plan and Vaccines Federal Implementation Plan.